Milestone Scientific Stock News

Zacks Investment Research downgraded shares of Milestone Scientific (NYSEAMERICAN:MLSS) from a hold rating to a sell rating in a research note published on Thursday, Zacks.com reports. According to Zacks, Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The []

Milestone Scientific (NYSEAMERICAN:MLSS) issued its quarterly earnings results on Monday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, meeting the Zacks consensus estimate of ($0.03), MarketWatch Earnings reports. Milestone Scientific had a negative return on equity of 36.31% and a negative net margin of 80.99%. Shares of MLSS opened at $2.45 []

Milestone Scientific (NYSEAMERICAN:MLSS) released its quarterly earnings results on Monday. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, hitting the Thomson Reuters consensus estimate of ($0.03), MarketWatch Earnings reports. Milestone Scientific had a negative net margin of 80.99% and a negative return on equity of 36.31%. Milestone Scientific stock traded []

Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q3 2021 Results - Earnings Call Transcript

Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -50.00% and -6.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for t

ROSELAND, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended September 30, 2021.

Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global p

Milestone Scientific Inc (NYSE:MLSS) reported a 69% uplift in revenue in its third quarter to end-September compared to last year, as dental offices began opening up again and the group's medical sale

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod

Milestone Scientific Inc. (NYSE:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, said it has added three new international distributors for th

Signs distributors in Canada, Slovenia and United Arab Emirates; expands commercial usage at leading hospital in Germany Signs distributors in Canada, Slovenia and United Arab Emirates; expands commer

ROSELAND, NJ / ACCESSWIRE / October 5, 2021 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today

Milestone Scientific Inc told investors that its sales force expansion was paying off, as the company had won approval to supply its CompuFlo Epidural and CathCheck Verification System disposables acr